PHARMACOKINETICS AND TOXICITY OF INHALED HUMAN INTERFERON-ALPHA IN PATIENTS WITH LUNG-CANCER

被引：38

作者：

KINNULA, V ^{[1
]}

MATTSON, K ^{[1
]}

CANTELL, K ^{[1
]}

机构：

[1] NATL PUBL HLTH INST,SF-00280 HELSINKI 28,FINLAND

来源：

JOURNAL OF INTERFERON RESEARCH | 1989年 / 9卷 / 04期

关键词：

D O I：

10.1089/jir.1989.9.419

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：419 / 423

页数：5

共 14 条

[1]

BEREK JS, 1985, CANCER TREAT REV, V12, P23

[2] EVALUATION OF ROUTES OF ADMINISTRATION OF INTERFERON IN CANCER - A REVIEW AND A PROPOSAL [J].

BOCCI, V .

CANCER DRUG DELIVERY, 1984, 1 (04) :337-351

[3] PULMONARY CATABOLISM OF INTERFERONS - ALVEOLAR ABSORPTION OF I-125-LABELED HUMAN INTERFERON-ALPHA IS ACCOMPANIED BY PARTIAL LOSS OF BIOLOGICAL-ACTIVITY [J].

BOCCI, V ;

PESSINA, GP ;

PACINI, A ;

PAULESU, L ;

MUSCETTOLA, M ;

MOGENSEN, KE .

ANTIVIRAL RESEARCH, 1984, 4 (04) :211-220

[4]

BRALEY JF, 1980, J CLIN INVEST, V61, P1240

[5]

Cantell K, 1981, Methods Enzymol, V78, P29

[6] PHARMACOKINETICS OF HUMAN LEUKOCYTE INTERFERON [J].

CANTELL, K ;

PYHALA, L .

JOURNAL OF INFECTIOUS DISEASES, 1976, 133 :A6-A12

[7]

Cantell K, 1981, Methods Enzymol, V78, P499

[8]

CANTELL K, 1974, J GEN VIROL, V22, P453

[9]

DOMINGUEZ EA, 1967, LAB INVEST, V16, P905

[10] INTRAPLEURAL APPLICATION OF HUMAN-LEUKOCYTE INTERFERON (HLI) IN BREAST-CANCER PATIENTS WITH IPSILATERAL PLEURAL CARCINOMATOSIS [J].

JEREB, B ;

USKRASOVEC, M ;

CERVEK, J ;

SOOS, E .

JOURNAL OF INTERFERON RESEARCH, 1987, 7 (04) :357-363

← 1 2 →